Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

JAFKX vs. JDOC: which is better?

Bottom line

JAFKX vs JDOC: the short answer

JAFKX (Health Sciences Trust) and JDOC (JPMorgan Healthcare Leaders ETF) are both mutual funds.

But JAFKX is far broader, holding 173 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.

JDOC is cheaper at 0.65% vs 1.24% — a difference of $59 a year per $10,000 invested.

Over one year, JAFKX returned +19.2% vs +14.9% for JDOC.

Updated Nov 19, 2026

JAFKX vs JDOC side by side

JAFKXJDOC
TypeMutual fundETF
Fund familyJohn HancockJ.P. Morgan
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.24%0.65%
Annual cost per $10k$124$65
10-yr cost on $10k (prospectus)$1,510$810
Max front load—None
12b-1 fee0.25%—
1-yr return+19.2%+14.9%
5-yr return (annualized)+3.9%—
10-yr return (annualized)+8.5%—
Best quarter—+11.3%
Worst quarter—−11.9%
Net assets (fund)$251.3M$9.1M
Number of holdings17361
Portfolio turnover68%92%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

13 of JAFKX's top 25 holdings also appear in JDOC's top 25.

Shared top holdings
HoldingJAFKXJDOC
Eli Lilly and Company14.30%7.76%
Johnson and Johnson6.33%4.82%
UnitedHealth Group Incorporated5.95%5.85%
AbbVie Inc.5.28%7.85%
Merck and Co. Inc.4.21%4.82%
Thermo Fisher Scientific Inc.2.67%3.73%
Bristol-Myers Squibb Company2.22%3.57%
Abbott Laboratories2.00%3.11%
Intuitive Surgical Inc.1.98%1.93%
Stryker Corporation1.87%2.23%
Danaher Corporation1.51%2.16%
Cardinal Health Inc.1.09%1.51%
CVS Health Corporation0.98%2.83%

Source: SEC Form N-PORT

JAFKX top 10

  1. Eli Lilly and Company — 14.30%
  2. Johnson and Johnson — 6.33%
  3. UnitedHealth Group Incorporated — 5.95%
  4. AbbVie Inc. — 5.28%
  5. Merck and Co. Inc. — 4.21%
  6. Gilead Sciences Inc. — 2.95%
  7. Thermo Fisher Scientific Inc. — 2.67%
  8. Vertex Pharmaceuticals Incorporated — 2.38%
  9. Bristol-Myers Squibb Company — 2.22%
  10. Abbott Laboratories — 2.00%

JDOC top 10

  1. AbbVie, Inc. — 7.85%
  2. Eli Lilly & Co. — 7.76%
  3. UnitedHealth Group, Inc. — 5.85%
  4. Merck & Co., Inc. — 4.82%
  5. Johnson & Johnson — 4.82%
  6. AstraZeneca plc — 3.76%
  7. Thermo Fisher Scientific, Inc. — 3.73%
  8. Bristol-Myers Squibb Co. — 3.57%
  9. Abbott Laboratories — 3.11%
  10. CVS Health Corp. — 2.83%

FAQ

What is the difference between JAFKX and JDOC?
JAFKX (Health Sciences Trust) and JDOC (JPMorgan Healthcare Leaders ETF) are both mutual funds. But JAFKX is far broader, holding 173 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.
Which is cheaper, JAFKX or JDOC?
JDOC has the lower expense ratio (0.65%).
Should I own both JAFKX and JDOC?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.